[ad_1]
Pfizer / BioNTech ad mentions LSE professor Elijah Mosialos in a post on Facebook, noting that the news is extremely about vaccine effectiveness rates for coronavirus. Specifically, it states:
“With today’s announcement, and after re-analysis of their vaccine clinical trial data, Pfizer / BioNTech determine the effectiveness of their vaccine at 95% (of the 90% they initially announced).
95% results from the general results of the study. Of the 170 confirmed cases of participants who became ill, 162 were seen in patients who had received the placebo vaccine. Only 8 out of 170 had been vaccinated with the Covid-19 vaccine.
In addition, this time there was a report of cases in which the participants developed a serious disease: only one of the vaccinated study participants developed a serious disease in the 10 cases observed. This is also very important because it means that the action of the vaccine not only protects against minor illnesses.
Excellent news that I hope will be confirmed by the publication of the data in scientific journals ”.
News Today
Today the presentation of the Greek plan for the free vaccination of citizens against Covid-19
Who is excluded and who benefits from the extension of expired checks
USA-Elections 2020: Trump fires director of Cybersecurity and Infrastructure Security
